172525 RESULTS

Head of Worldwide Development for a Phase III AD Therapeutic

JOB 2014-12-29 Employer Roivant Sciences, Inc. Principal Investigator Lawrence Friedhoff Contact Description Roivant recently acquired the rights to a Phase 3 drug for the treatment of Alzheimer’s disease.  The drug has demonstrated  ...

Stem Cell Summit 2015

CONFERENCE 2015-04-27 00:00:00-2015-04-29 00:00:00 Hyatt Regency Boston Hotel, Boston, Massachusetts, U.S.A. 27 &#x2013 29 April 2015 The summit includes two parallel conferences thatinclude joint sessions. GTCbio's Stem Cell Summit 2015 provides cutting-edge information on developments in all ...

Antibody Probe Seeks Aβ Oligomers in MRI

RESEARCH NEWS 2014-12-29 Research News Aβ oligomers are widely seen as the cause of synaptic damage and cognitive decline in Alzheimer’s disease. Researchers want to be able to detect these peptides in vivo to better diagnose and track the progression of AD. In an effort to ...

Regarding Choosing Alzheiemer mouse model

Other Research Models Hi, Anyone can let me know that for "Transcriptomic analysis of the Type 2 Diabetes induced Alzheimer disease in mice model" which mice model I should choose. Though I come to know about TAPP transgenic mice model (Ref: 1. ...

Current Filters

No filters selected

Filter By

  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From